New diabetes drug aims for better blood sugar control
NCT ID NCT07472725
First seen Mar 16, 2026 · Last updated May 01, 2026 · Updated 5 times
Summary
This study tests a new medicine called SHR-3167 in adults with type 2 diabetes whose blood sugar is not well managed by current pills. About 90 people will receive different doses to see how safe it is and how well it controls blood sugar. The main goal is to check for low blood sugar events and measure changes in HbA1c over 20 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, 210003, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Peking University Shenzhen Hospital
Shenzhen, Guangdong, 518000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.